Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

NCT00643890 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped Due to financial reasons

Conditions

Parkinson's Disease

Interventions

GENETIC: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus

Sponsor

Neurologix, Inc.